A complete application in a minute
Tailored resume and cover letter, ready to send.
Iovance Biotherapeutics, Inc. seeks a Senior Manager, U.S. Market Access Marketing to translate clinical and economic evidence into differentiated value messaging for AMTAGVI and pipeline therapies.
The role shapes the US market access strategy across payer and provider channels, focusing on financial feasibility, PIE, budget impact, site of care, and cost‑effectiveness. You will lead cross‑functional collaboration with HEOR/RWE, Brand Marketing, Medical Affairs, and commercial teams; travel up
Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The Iovance TIL platform spans registrational trials and next‑generation programs in additional solid tumors, including gene‑edited and IL‑12 tethered TIL therapies, next‑generation IL‑2, and precision immuno‑oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end‑to‑end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit www.iovance.com .
Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners.
Information on Iovance's broad, industry‑leading patent portfolio is available on the Intellectual Property page on www.iovance.com .
In the U.S. Cell and Gene therapy (CGT) market, access decisions span Commercial and Government Health Plans as well as clinical, formulary, finance, and value‑analysis stakeholders within Authorized Treatment Centers (ATCs), integrated delivery networks (IDNs), and other provider organizations. Iovance is seeking a Senior Manager, U.S. Market Access Marketing, to translate clinical and economic evidence into differentiated value messaging and resources for AMTAGVI and pipeline therapies.
This individual will help shape and lead tactical execution of the U.S. market access strategy across payer and provider channels, focusing on ATC financial feasibility, pre‑approval information exchange (PIE), total cost of care, site of care, budget impact, and cost‑effectiveness.
The physical demands described here represent